Local Open-label Multicenter Study to Assess the Effectiveness of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis in Russian Clinical Practice
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 08 Oct 2018
At a glance
- Drugs Pirfenidone (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Therapeutic Use
- Sponsors Roche
- 28 Sep 2018 Status changed from recruiting to active, no longer recruiting.
- 16 Jul 2018 Planned End Date changed from 24 Jun 2019 to 24 Jun 2020.
- 16 Jul 2018 Planned primary completion date changed from 24 Jun 2019 to 24 Jun 2020.